Xuanzhu Biopharmaceutical Co., Ltd. (HKG:2575)
Hong Kong · Delayed Price · Currency is HKD 22.00
-0.94 (-4.10%)
May 12, 2026, 4:08 PM HKT
Xuanzhu Biopharmaceutical Market Cap
Xuanzhu Biopharmaceutical has a market cap or net worth of 11.88 billion as of May 12, 2026.
Market Cap
11.88B
Enterprise Value
11.16B
Revenue
57.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
22.00
Market Cap Chart
Since October 15, 2025, Xuanzhu Biopharmaceutical's market cap has decreased from 13.62B to 11.88B, a decrease of -12.78%. That is a compound annual growth rate of -21.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 11.88B | -67.46% |
| Dec 31, 2025 | 36.52B | 168.06% |
| Oct 15, 2025 | 13.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Consun Pharmaceutical Group | 12.87B |
| CanSino Biologics | 12.34B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Sihuan Pharmaceutical Holdings Group | 11.03B |
| Luye Pharma Group | 10.43B |
| Shandong Xinhua Pharmaceutical Company | 9.52B |
| CF PharmTech | 9.01B |
| China Traditional Chinese Medicine Holdings Co. | 8.61B |